We invest in early-stage technologies with a focus on therapeutics, medical devices, and diagnostics. We look for potential investments at the proof-of-concept stage. We fund outstanding science, supported by deep subject matter expertise, to build innovative companies that transform healthcare and impact the lives of patients.